<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T07:38:26Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/8796" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/8796</identifier><datestamp>2025-10-24T10:21:53Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Mechanical thrombectomy with a novel device: initial clinical experience with the ANA thrombectomy device</dc:title>
   <dc:creator>Tomasello Weitz, Alejandro</dc:creator>
   <dc:creator>Requena Ruiz, Manuel</dc:creator>
   <dc:creator>Liebeskind, David</dc:creator>
   <dc:creator>Ribó Jacobi, Marc</dc:creator>
   <dc:creator>Hernandez Morales, David</dc:creator>
   <dc:creator>Piñana Plaza, Carlos</dc:creator>
   <dc:creator>Nogueira, Raul</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Tomasello A, Hernandez D, Piñana C] Servei de Neuroradiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Requena M, Ribo M] Unitat d’Ictus, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Liebeskind DS] Neurovascular Imaging Research Core and University of California Los Angeles Stroke Center, Department of Neurology, University of California, Los Angeles, CA, USA. [Nogueira RG] Department of Neurology, Neurosurgery and Radiology, Emory University School of Medicine, Atlanta, GA, USA</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Vasos sanguinis - Cirurgia</dc:subject>
   <dc:subject>Malalties cerebrovasculars</dc:subject>
   <dc:subject>Avaluació de resultats (Assistència sanitària)</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Cardiovascular Surgical Procedures::Vascular Surgical Procedures::Thrombectomy::Mechanical Thrombolysis</dc:subject>
   <dc:subject>DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders::Stroke</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos cardiovasculares::procedimientos quirúrgicos vasculares::trombectomía::trombólisis mecánica</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares::accidente cerebrovascular</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento</dc:subject>
   <dc:description>Mechanical thrombectomy; New device; Stroke</dc:description>
   <dc:description>Trombectomia mecànica; Nou dispositiu; Ictus</dc:description>
   <dc:description>Trombectomía mecánica; Nuevo dispositivo; Ictus</dc:description>
   <dc:description>Introduction&#xd;
The ANA™ (Anaconda Biomed) thrombectomy system is a novel stroke thrombectomy device comprising a self-expanding funnel designed to reduce clot fragmentation by locally restricting flow while becoming as wide as the lodging artery. Once deployed, ANA allows distal aspiration in combination with a stentretriever (SR) to mobilize the clot into the funnel where it remains copped during extraction. We investigate safety and efficacy of ANA™ in a first-in-man study.&#xd;
Methods&#xd;
Prospective data was collected on 35 consecutive patients treated as first line with ANA™ at a single centre. Outcome measures included per-pass reperfusion scores, symptomatic intracerebral hemorrhage (sICH), NIHSS at day 5, and mRS at 90 days.&#xd;
Results&#xd;
Median NIHSS was 12(9−18). Sites of primary occlusion were: 5 ICA, 15 M1-MCA, 15 M2-MCA. Primary performance endpoint, mTICI 2b-3 within 3 passes without rescue therapy was achieved in 91.4% (n = 32) of patients; rate of complete recanalization (mTICI 2c-3) was 65.7%. First pass complete recanalization rate was 42.9%, and median number of ANA passes 1(IQR: 1−2). In 17.1% (n = 6) rescue treatment was used; median number of rescue passes was 2(1–7), leading to a final mTICI2b-3rate of 94.3% (n = 33). There were no device related serious adverse events, and rate of sICH was 5.7% (n = 2). At 5 days median NIHSS was 1 (IQR 1−6) and 90 days mRS 0−2 was achieved in 60% of patients.&#xd;
Conclusions&#xd;
In this initial clinical experience, the ANA™ device achieved a high rate of complete recanalization with a good safety profile and favourable 90 days clinical outcomes.</dc:description>
   <dc:description>The study was funded by Anaconda Biomed S.L.</dc:description>
   <dc:date>2023-01-10T08:27:40Z</dc:date>
   <dc:date>2023-01-10T08:27:40Z</dc:date>
   <dc:date>2022-06</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Tomasello A, Hernandez D, Piñana C, Requena M, Liebeskind DS, Nogueira RG, et al. Mechanical thrombectomy with a novel device: initial clinical experience with the ANA thrombectomy device. J Neuroradiol. 2022 Jun;49(4):324–8.</dc:identifier>
   <dc:identifier>1773-0406</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/8796</dc:identifier>
   <dc:identifier>10.1016/j.neurad.2020.11.003</dc:identifier>
   <dc:identifier>33340641</dc:identifier>
   <dc:identifier>000818010600004</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/8796</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Journal of Neuroradiology;49(4)</dc:relation>
   <dc:relation>https://doi.org/10.1016/j.neurad.2020.11.003</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>